Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Nature of Disclosure: Intimation of appointment of statutory auditors
Key Decision: The Board of Directors of Samrat Pharmachem Limited, at its meeting held on July 15, 2026, approved the appointment of Divyesh J Shah & Associates, Chartered Accountants, as the company's Statutory Auditors.
Meeting Details: The Board meeting commenced at 2:00 PM IST and concluded at 3:30 PM IST on July 15, 2026.
Appointment Details:
- Auditor Firm: Divyesh J Shah & Associates
- ICAI Firm Registration No.: 118227W
- Term: Five years
- Term Commencement: From conclusion of 34th Annual General Meeting
- Term Conclusion: Until conclusion of 39th Annual General Meeting
- Approval Status: Subject to approval of members (shareholders)
Background: The appointment was made pursuant to the recommendation of the Audit Committee of Directors.
Auditor Profile:
- Established in 1998
- Experience includes assignments by BSE for Inspection of Stock Brokers to find frauds
- Engaged in Statutory Bank Branch Audits and Debt Syndication
- Appointed in panel of CAs by Government of Maharashtra for state subsidy policy guidance & framework in 2012
- Engaged in Due diligence for Mergers & Acquisitions of businesses
- Firm Structure: Partnership firm
- Services Provided: Auditing, taxation, and management consultancy services to clients in India
Regulatory Compliance: This disclosure is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Additional Information: The disclosure has been made available on the company's website at www.samratpharmachem.com
Financial Impact: Not quantified in the disclosure.